ArticleAJPM focus2025
Cervical Cancer Screening Overuse Among Women With and Without Disability in the U.S. From 2007 to 2016.
Article in AJPM focus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Persons with disability, a recognized health disparity population with complex care needs, may be at risk for cervical cancer screening overuse. However, limited studies have examined cervical cancer screening overuse among women with and without disability using large nationally representative survey data. Among women with and without disability, the authors aimed to provide national estimates of cervical cancer screening overuse and the proportion of cervical cancer screening overuse among younger, middle-age, and older women. Methods: The authors first utilized the U.S. Preventive Services Task Force guidelines to conceptualize and define cervical cancer screening overuse for women with and without disability on the basis of age-based recommendations of Papanicolaou testing frequencies. The authors used the definition of disability to include limitations in mobility or walking, hearing, vision, or cognition, activities of daily living, or instrumental activities of daily living as well as limitations in school, work, or housework. The authors then used the Medical Expenditure Panel Survey data pooled from 2007 to 2016 to estimate the survey-weighted proportion of cervical cancer screening overuse among younger women (aged 17-20.9 years and 21-29.9 years), middle-age women (aged 30-64.9 years), and older women (aged ≥65 years). Results: The analytic sample comprised 101,083 women aged ≥17 years with and without disability or a survey-weighted population of 94.8 million, of whom 52.5% had no disability and 12.97% had any disability. There was a large difference in cervical cancer screening overuse between women with and without disability, with women without disability having much higher overuse rate. The survey-weighted proportion of cervical cancer screening overuse among middle-age women aged 30-64.9 years without disability and with disability was highest (52.5% vs 12.97%, Conclusions: Cervical cancer screening overuse is potentially occurring in women with and without disability, calling for a need to design multilevel interventions and economic incentives to deimplement low-value cervical cancer screening in healthcare delivery settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.